Glemont 4mg Tablet

Glemont 4mg Tablet contains montelukast, a leukotriene receptor antagonist used for the prevention and long-term control of asthma symptoms and for relief of symptoms of allergic rhinitis (seasonal or year-round nasal allergy symptoms). The 4mg strength is formulated as a chewable tablet for younger children, and it works by blocking leukotrienes, chemicals in the body that cause airway inflammation, swelling, and mucus production.

Glemont 4mg Tablet is a prescription-only medicine in Malaysia. It is only supplied after an online consultation with a doctor through DoctorOnCall, who will assess the child’s age, weight, and symptoms before issuing a prescription. It is used for the ongoing prevention of asthma symptoms and is not a reliever medicine for a sudden asthma attack.

Montelukast selectively blocks the cysteinyl leukotriene receptor (CysLT1) in the airway, preventing leukotrienes released during an allergic or inflammatory response from binding to their receptor. This reduces airway inflammation, bronchoconstriction, swelling of the airway lining, and excess mucus production, helping to prevent asthma symptoms and ease nasal allergy symptoms.

Glemont 4mg Tablet should only be given according to the dose and schedule prescribed by the doctor following an online consultation with DoctorOnCall. The chewable tablet should be chewed thoroughly before swallowing and is usually given once daily in the evening. It should be taken regularly, even when the child feels well, as it works to prevent symptoms rather than relieve a sudden attack.

The dosage of Glemont 4mg Tablet is determined individually by the prescribing doctor based on the child’s age and weight, and it is typically taken once a day in the evening as a preventive treatment. Always follow the exact dose and schedule given on the prescription, and do not use it to treat a sudden asthma attack, as it does not provide immediate relief.

Glemont 4mg Tablet is generally stable for up to 24 to 36 months from the date of manufacture when stored correctly and unopened. Always check the expiry date printed on the blister strip or carton before use, and do not use the tablets if the date has passed.

Store Glemont 4mg Tablet at room temperature, below 30 degrees Celsius, in a dry place away from direct sunlight and moisture, and keep it in the original packaging to protect it from light. Keep well out of reach and sight of children, even though the tablet is chewable and flavoured.

• Known hypersensitivity to montelukast or any ingredient in the tablet
• Not to be used as a reliever for an acute asthma attack or status asthmaticus
• Use with caution in children with a history of neuropsychiatric symptoms, and report any mood or behaviour changes to the doctor promptly
• Not recommended for children below the age approved for this strength without a doctor’s advice

• Phenobarbital and rifampicin may reduce montelukast blood levels
• Inform the doctor of all other medicines, supplements, and herbal products the child is taking
• Montelukast does not need to be timed around meals and can be taken with or without food
• Continue any other prescribed asthma medicines as directed, as Glemont 4mg Tablet is usually used alongside, not instead of, other asthma treatment

• Give Glemont 4mg Tablet once daily in the evening as advised, even when symptoms are well controlled
• Make sure the tablet is chewed properly and not swallowed whole
• Keep a reliever inhaler on hand at all times, as montelukast does not treat sudden breathing difficulty
• Watch for any changes in mood, sleep, or behaviour and report these to the doctor
• Attend scheduled follow-up visits so the doctor can monitor asthma control and adjust treatment if needed

Glemont 4mg Tablet is intended for long-term, preventive control of asthma and allergic rhinitis symptoms in young children and is not a substitute for a fast-acting reliever inhaler during an asthma attack. Regulatory authorities have highlighted that montelukast has been associated with neuropsychiatric side effects such as sleep problems, agitation, or mood changes in some patients, so parents and caregivers should be alert to any such changes and discuss them with the doctor. Ongoing follow-up helps the doctor assess how well the child’s asthma or allergy symptoms are being controlled and whether treatment needs to be adjusted.